ORLANDO — Genetic testing is warranted in patients with epilepsy of unknown origin, new research suggests. Investigators found that pathogenic genetic variants were identified in over 40% of patients ...

The trial clearance for Shanghai-based Unixell is another step forward for the rapidly advancing Chinese biotech ecosystem, ...

STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced Biogen (Nasdaq: BIIB), Praxis Precision Medicines ...

Noninvasive tests performed in midlife may help identify people who are at risk of late-onset epilepsy (LOE), a new study suggests. New data from the Framingham Heart Study show those who scored ...

Conor Butts spent the first part of his career in the IT space. A UT-Dallas graduate, he decided to pivot into something new, which prompted him to return to grad school at SMU and enroll in an ...

Researchers from Inserm and Grenoble Alpes University (UGA) have discovered a new therapeutic avenue for combating ...

Neurological diseases such as Parkinson’s disease, epilepsy, and schizophrenia affect millions of people around the world.

An international clinical trial has achieved a new effective treatment option for rare epilepsy that can reduce seizures by ...